By Tatiana Orlova 04-12-2020
In: hive-exclusives | COVID-19 Economics EM

After a Long Russian Winter, A Rate Cut Will Come

(3 min read)
Resize text:


Russia is in the middle of a second COVID-19 wave. As of 3 December, it had 2.35 million confirmed cases, the fourth-largest number globally. The official mortality count is 28 per 100,000 people, more than twice as high as in India but much lower than in the US, UK and the most-affected EU economies. Without action, however, the situation worsens: the daily number of new COVID cases in Russia has exceeded 28,000 and is still rising.

But vaccination has started. On 2 December, President Vladimir Putin declared the beginning of mass vaccination with Sputnik V, the first of the domestically developed vaccines to pass clinical trials. According to Russia’s Direct Investment Fund, which has sponsored the vaccine’s development by the Gamaleya institute, it is 95% effective. Medical workers and teachers will receive inoculation first, starting from next week – the government has reassured the population that vaccination will be voluntary and free of charge.

TO READ THIS HIVE EXCLUSIVE
SUBSCRIBE TO MACRO HIVE PRIME

£39/month thereafter

For access to our Slack Chat Room, where we discuss all things markets with our researchers and subscribers

START YOUR FREE TRIAL


MOST READ

Successful Start-Ups Build Strong Founding Teams (4 min read)

By Sam van de Schootbrugge | Feb 10, 2021
Start-up success hinges on many factors, but most would agree that the skills and experience of the founder and initial founding...

Where Will the Economy Find 10 million Lost Jobs? (3 min read)

By John Tierney | Feb 08, 2021
The headline January labour market report was another downer – private payrolls rose a scant 6,000 versus the consensus...

Where Can you Get Higher Bond Yields?

By Caroline Grady | Dec 04, 2020
US yields are rising. The combination of growing optimism over a global recovery given vaccine progress, and the possibility of a US...

PREMIUM CONTENT

The Fed is Failing (1 min read)

By Bilal Hafeez | Mar 01, 2021
The Fed’s failure is neither that rates…

Do ESG Ratings Affect IPO Valuations? (4 min read)

By Sam van de Schootbrugge | Mar 03, 2021
Summary A new Journal of Corporate Finance…

Want To Join Our Community Of Leading Investors And Researchers In Our Slack Chat Room?